·Anthony S. Fauci, M.D, 2010, Nation instute of ALlerfyt and Infectious Disease,, Immune System
Marieb, E.N., Hoehn, K. (2007) Human Anatomy and Physiology, 7th edn, Benjamin Cummings New York.

·Blanco, P., Oaluckad, A., Pascuald, V. & Banchereaud, J. 2009, "Dendritic Cells and cytokines in human inflammatory and autoimmune dieseases", PMC, vol. 19, no. 1, pp. 41-52.

  • ·Bogaert, D. Weinberger, D. Thompson, C. Lipsitch, M. & Malley, R, 2009., Imparied Innate and Adaptive Immunity toStreptococcus pneumonia and its Effects on Colonization in an Infant Mouse Model, American Society for Microbiology, 77: 1613-1622.

· ·Jaspan, H. Lawn, S. Safrit, J. & Bekker, L, 2006, The maturing immune system: implications of development and testing HIV-1 vaccines for children and adolescents, AIDS, 20: 483-494.

· ·Liu, G. Zhang, L. & Zhao, Y, 2010, Modulation of immune responses through direct activation of Toll-like receptors to T cells,The Journal of Translational Immunology, 160: 168-175.

· ·Netea, M. Van Der Graaf, C. Van Der Meer, J & Kullberg, B, 2004, Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system, Journal of Leukoeyte Biology, 75: 749-755.

· ·Gallorini, S. Berti, F. Mancuso, G. Cozzi, R. Tortoli, M. Volpini, G. Telford, J. Beninati, C. Maione, D. & Wack, A, 2009, Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides,PNAS, 106: 17481-17486.

· ·Jane, V. & Levy, O, 2009, Developmental Biology of the Innate Immune Response: Implication for Neonatal and Infant Vaccine Development, The International Pediatric Research Foundation, 65: 98-105.

· ·Plotkin, S & Mortimer, E. 1988, Vaccines, 2nd edn, Philadelphia, United States.

· ·Anderson, K.V., Bokla, L. & Nüsslein-Volhard, C. 1985, "Establishment of dorsal - ventral polarity in the drosophila embryo: The induction of polarity by the Toll Gene product", Cell, vol. 42, no. 3, pp. 791-798.

· ·Flanagan, K.L., Burl, S. & Plebanski, M. 2010, "The Challenge of Assessing Infant Vaccine Responses in Resource poor Settings", Medscape Today, [Online], vol. 9, no. 6, pp. 2/9/2010. Available from: [2/9/2010].

· ·Levy, O., Suter, E.E., Miller, R.L. & Wessels, M.R. 2008, "Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells", Blood, vol. 108, no. 4, pp. 1284-1290.

· ·Medzhitov, R., Hurlburt, P. & Janeway, C. 1997, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, vol. 388, no. 1, pp. 394-397.
· ·Nerren, J.R., He, H., Genovese, K.J. & Kogut, M.H. 2009, "mRNA Expression of the Avian Specific Toll-Like Receptor 15 is induced by Multiple Species of Bacteria", The Journal of Immunology, vol. 182, no. 135, pp. 135-135.
  • Norman, B. 2010, First evidence that the brain's native dendritic cells can muster an immune response, The Rockefeller University

· ·Rottinghaus, E., Vesosky, B. & Turner, J. 2010, "Elderly might not benefit from TB vaccines in development", Mechanisms of Ageing and Development, vol. 131, no. 6, pp. 605-614.

· ·Schnare, M., Barton, G.M., Holt, A.C., Takeda, S. & Medzhitov, R. 2001, "Toll-like receptors control activation of adaptive immune responses", Nature, vol. 2, no. 10, pp. 947-950.

  • Siegrist, C. 2008, "Section 1, General aspects of vaccination: Vaccine immunology" in Vaccines, 5th edn, Saunders, , pp. 17-35

· ·Shaw, A. 2008, "Vaccines Incorporating Toll-like Receptor Ligands", 2008, [Online], vol. 1, no. 1, pp. 1/9/2010. Available from: [1/9/2010].
  • Steinman, M.,R. & Pope, M. 2002, "Exploiting dendritic cells to improve vaccine efficieny", The Journal of Clinical Investigation, vol. 109, no. 12, pp. 1519-26

  • Turley, S. 2002, "Denditic cells: inciting and inhibiting autoimmunity", Current Opinion in Immunilogy, vol. 14, pp. 765-770.

  • Upham, J., Rate, A., Rowe, J., Kusel, M., Sly, P. & Holt, P. 2006, "Dendritic Cell Immaturity during Infancy Restricts the Capacity To Express Vaccine-Specific T-Cell Memory", Infection and immunity, [Online], vol. 74, no. 2, pp. 1106-. [2005]

  • Vogel, F. 2000, "Improving Vaccine Performance with Adjuvants", Clinical Infectious Diseases, , no. 30, pp. 266-270

· ·Antibody 2010, in MedlinePlus encyclopaedia, viewed 28 September 2010, MedlinePlus Online,

· ·Beaver, C, 2010, ‘Strategic immunogenicity testing’, [[file:/C:\Users\44984\Documents\Sidz\2010\semester 2\com in Science\Essay\Essay V2.doc|Applied Clinical Trials]], Vol. 19 Issue 6, p82-90.

  • Duthie, S.M, Kimber, I, and Norval, M, 1999, ‘The effects of ultraviolet radiation on the human immune system’, British Journal of Dermatology, 140: pp. 995–1009

  • Linder N, Abudi Y, Abdalla W, Badir M, Amitai Y, Samuels J, Mendelson E and Levy F, 2009, ‘Effect of Season of Inoculation on Immune Response to Rubella Vaccine in Children’, Journal of Tropical Pediatrics Advance Access. doi:10.1093/tropej/fmp104

  • Peña-Cruz, V, McDonough, M.S, Diaz-Griffero, F, Crum, P.C, Carrasco, D.R, Freeman, J.G, 2010, Langerhans Cells Regulate Antigen-Presenting Cell Activity’, [[file:/C:/Users/44984/Documents/Sidz/2010/semester 2/com in Science/Essay/Essay V2.doc|Journal of Investigative Dermatology]],// Vol. 130 Issue 9, pp. 2222-2230